Sanofi and Regenerons jointly developed Dupixent has received a positive opinion from the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending approval for treating chronic spontaneous urticaria in children aged two to 11 who havent responded to antihistamines, potentially making it the first targeted therapy in this age group in the EU if finalized
BPC-157 assists in stabilizing the brain-gut axis which controls how the brain, gut, microbiome and immune system interact
The double blind, randomized, placebo controlled trials were done in 16 countries in Asia, Europe, North and South America
Semaglutide likely provokes hiccups by sensitizing the hiccup reflex to peripheral signals from the gut and by altering brainstem excitability
Like other treatments, it has mild effects, such as injection-site pain, headache, or nausea, which may occur
patients and healthcare providers were advised to verify lot and serial numbers